Fas ligand (FasL/CD95L) is best known for its role in delivering apoptotic signals through its receptor, Fas (APO-1/CD95). In this study, we present evidence that FasL has a second role as a signaling receptor. Alloantigen-specific proliferation by multiple FasL− murine CTL lines is depressed compared to that of FasL+ CTL lines. FasL− CTLs kill efficiently on a per recovered cell basis and can achieve wild-type levels of proliferation upon stimulation by optimal doses of anti-CD3, suggesting the lack of a costimulatory signal during antigen stimulation. To test this hypothesis directly, soluble FasIgG, a fusion protein of murine Fas and human IgG1, was added to FasL+ CTLs to demonstrate that blocking cell surface Fas–FasL interactions mimics the depression observed for FasL− CTLs. In addition, plate-bound FasIgG in conjunction with suboptimal anti-CD3 stimulation augments proliferative signals in FasL+ but not FasL− CTLs. In contrast to these results with CD8+ T cells, alloantigen-stimulated FasL− CD4+ T cells proliferate vigorously compared to FasL+ cells. These data demonstrate that reverse signaling through FasL is required for CTLs to achieve maximal proliferation and may provide clues to differences in the homeostatic regulation of activated CD4+ and CD8+ T cells during an immune response.
Skip Nav Destination
Article navigation
5 January 1998
Brief Definitive Report|
January 05 1998
Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand
Ivy Suzuki,
Ivy Suzuki
From the Department of Immunology, University of Washington, Seattle, Washington 98195
Search for other works by this author on:
Pamela J. Fink
Pamela J. Fink
From the Department of Immunology, University of Washington, Seattle, Washington 98195
Search for other works by this author on:
Ivy Suzuki
From the Department of Immunology, University of Washington, Seattle, Washington 98195
Pamela J. Fink
From the Department of Immunology, University of Washington, Seattle, Washington 98195
Address correspondence to Dr. Pamela J. Fink, University of Washington, Department of Immunology, Box 357650, Rm H574A, Seattle, WA 98195. Phone: 206-685-3608; Fax: 206-616-7237; E-mail: [email protected]
Received:
August 04 1997
Revision Received:
October 29 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (1): 123–128.
Article history
Received:
August 04 1997
Revision Received:
October 29 1997
Citation
Ivy Suzuki, Pamela J. Fink; Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand . J Exp Med 5 January 1998; 187 (1): 123–128. doi: https://doi.org/10.1084/jem.187.1.123
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement